1053 Preclinical pharmacodynamic characterization of STK-026: a novel IL-12 partial agonist for cancer with maintained CD8 T cell activity, reduced NK-mediated toxicity and an impr... by Koliesnik, Zhenya, Totagrande, Michael, Burgess, Ryan, Tran, Kim Q, Bauer, Michele, Jayaraman, Bharghavi, Buffone, Cindy, Balasubrahmanyam, Priyanka, Emmerich, Jan, Chaturvedi, Deepti, Rokkam, Deepti, Malefyt, Rene De Waal, Greb, Heiko, Ratti, Navneet, Vivona, Sandro, Kastelein, Robert, Lupardus, Patrick, Zuniga, Luis, Rosen, David B, Oft, Martin

Get full text